Effect of cholinesterase inhibitors on the susceptibility to pentetrazole of the mouse.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D051379:Mice; D009388:Neostigmine / Q000494:pharmacology; D010095:Oxotremorine / Q000494:pharmacology; D010261:Paraoxon / Q000494:pharmacology; D010433:Pentylenetetrazole; D010830:Physostigmine / Q000494:pharmacology; D012640:Seizures / Q000139:chemically induced*; D014191:Tranylcypromine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D014191:Tranylcypromine; D010095:Oxotremorine; D008464:Mecamylamine; D001285:Atropine; D010830:Physostigmine; D010261:Paraoxon; D010433:Pentylenetetrazole